Daily or weekly? How Wegovy injections actually work

Wegovy is injected once every seven days — the same day each week, chosen to fit your life.
Treatment starts at a low 0.25 mg dose and is titrated upward roughly every four weeks by your prescriber, not by you.
Each pre-filled pen is for single use; the injection goes under the skin of your abdomen, thigh, or upper arm.
A new higher 7.2 mg pen, approved by the MHRA on 14 April 2026, means the maximum maintenance dose has increased beyond the previous 2.4 mg ceiling.

Wegovy is a once-weekly injection, not a daily one. You take one dose every seven days, on whatever day suits your routine, and keep that day consistent throughout treatment. It contains semaglutide, a GLP-1 receptor agonist that reduces appetite and slows gastric emptying. Because it is a prescription-only medicine, a prescriber assesses your suitability before any treatment begins. Read the full Wegovy overview if you're starting from scratch, or keep reading for the practical detail on how the weekly schedule is structured and what choosing the right day actually means for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the weekly schedule and what it means in practice

Why weekly rather than daily?

The reason Wegovy works on a weekly cycle comes down to how semaglutide behaves once it is absorbed. Its half-life in the body is roughly one week, which means a single injection sustains an effective concentration across the full seven days. If you are curious about whether Wegovy is a daily injection, the short answer is that it is not, and if you want to understand what a daily semaglutide injection would actually involve, our dedicated page explains why that format would not improve results and would simply add unnecessary burden.

That long action profile is also why missing a day does not apply in the way it might with a tablet. There are no daily doses to forget; there is one weekly event to anchor to your calendar. A question our prescribers hear often is whether it matters which day you pick. It does not matter which specific day, but it matters that you keep it consistent week to week. Shifting your injection day by a day or two occasionally is manageable, but irregular timing is not ideal and any questions about it belong with your prescriber rather than a general guide like this one.

The NHS patient-level information on semaglutide walks through the schedule in plain language if you want an independent reference alongside what your prescriber tells you.

How the dose increases across the weekly schedule

The weekly injection is not the same dose throughout treatment. Wegovy follows a stepped titration: the starting dose is 0.25 mg per week, held for roughly four weeks while your system adjusts, then your prescriber moves you through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose. Each step takes about a month.

Since the MHRA approved a dedicated single-dose 7.2 mg pen on 14 April 2026, some patients on the highest doses may be titrated further under clinical guidance. The weekly injection page has more detail on how each pen format works in practice.

The dose-increase timing is decided by your prescriber, not by how you feel subjectively. Rushing the titration is one of the commonest causes of unnecessary nausea. If you want to understand how the semaglutide weekly injection works and why the weekly format was chosen over a daily alternative, our dedicated page covers the tolerability rationale behind the stepped schedule in more detail.

On the cost side, each step up changes the pen you receive. If you are thinking about what treatment costs across the titration period, our guide to Wegovy pricing in the UK sets out what a transparent private prescription actually includes.

Choosing your injection day and building a routine

Because Wegovy is weekly, the practical decision is simpler than people expect: pick one day, pick a time within that day that you can reliably repeat, and stick to it. Some people attach it to a regular weekly event — a Monday morning before the school run, a Sunday evening after a walk. The pen does not need to be taken at the same hour to the minute, but the same-day rhythm matters.

Storage is worth thinking through early. Wegovy pens are refrigerated between 2°C and 8°C; a slot in the fridge door works well, away from the freezer section where temperatures can dip too low. Once removed from the fridge, there is a limited window for room-temperature storage, always check the Patient Information Leaflet in your box for the exact figures, because they vary slightly by pen format and the SmPC on the electronic Medicines Compendium is the authoritative source for storage detail.

For injection technique, the pen goes under the skin at your abdomen, thigh, or upper arm, rotating sites each week. Alcohol swabs for cleaning the site before injection are a low-cost practical addition to your routine. The full technique guidance is in your leaflet.

Who decides whether Wegovy's weekly injection is right for you

Wegovy is a prescription-only medicine. No amount of reading a schedule can substitute for a clinical assessment. The prescriber reviews your BMI, your weight-related health conditions, your current medicines, and other relevant factors before deciding whether semaglutide is appropriate and at what starting dose.

The licensed eligibility thresholds are a BMI of 30 or above, or a BMI from 27 upward alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. NICE's appraisal of semaglutide for weight management sets out the clinical framework that informs prescribing decisions. There is also a newer oral option, approved in June 2026, for people who prefer not to inject at all, our weight loss treatment overview covers the full range of licensed options.

At nume, every consultation is read by a GPhC-registered Independent Prescriber the same day. If you are clinically suitable and order before midday on a weekday, your treatment is dispatched that day and delivered free the next working day by DPD, in plain packaging. When you are ready to take the next step, start your free consultation and a prescriber will review your details the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions